The Edwards-Hunt Group was formed to facilitate basic and clinical research by implementing contemporary solutions for today’s translational medicine challenges. The Edwards-Hunt Group provides inclusive, multi-level consulting services to the non-profit arena, commercial biorepositories and the pharmaceutical and diagnostic industries
Alicia Sable-Hunt, founder of the Edwards-Hunt Group, works from the premise that biobanking is the foundation for precision medicine. In an effort to see this model become reality, Ms. Hunt founded a life science consulting firm to fully support non-profit organizations developing translational medicine programs in order to drive drug development in the direction of their particular disease.
In addition, Ms. Hunt expanded the firm to include an international biospecimen acquisition network offering the pharmaceutical and diagnostic industries prospective collection of human tissue and blood specimens and supporting clinical research services.
In order to successfully manage this effort, the Edwards-Hunt Group offers a broad range of services to non-profit organizations and the pharmaceutical and diagnostic industries. Services begin with initial strategic development planning and culminates with tactical implementation.